IBDEI159 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20494,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,20494,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,20494,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,20495,0)
 ;;=V19.5^^131^1289^13
 ;;^UTILITY(U,$J,358.3,20495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20495,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,20495,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,20495,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,20496,0)
 ;;=V19.2^^131^1289^14
 ;;^UTILITY(U,$J,358.3,20496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20496,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,20496,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,20496,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,20497,0)
 ;;=V17.3^^131^1289^16
 ;;^UTILITY(U,$J,358.3,20497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20497,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,20497,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,20497,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,20498,0)
 ;;=V16.6^^131^1289^17
 ;;^UTILITY(U,$J,358.3,20498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20498,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,20498,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,20498,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,20499,0)
 ;;=V18.61^^131^1289^19
 ;;^UTILITY(U,$J,358.3,20499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20499,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,20499,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,20499,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,20500,0)
 ;;=V17.0^^131^1289^20
 ;;^UTILITY(U,$J,358.3,20500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20500,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,20500,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,20500,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,20501,0)
 ;;=V19.4^^131^1289^21
 ;;^UTILITY(U,$J,358.3,20501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20501,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,20501,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,20501,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,20502,0)
 ;;=V17.1^^131^1289^22
 ;;^UTILITY(U,$J,358.3,20502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20502,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,20502,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,20502,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,20503,0)
 ;;=V16.8^^131^1289^12
 ;;^UTILITY(U,$J,358.3,20503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20503,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,20503,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,20503,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,20504,0)
 ;;=V11.1^^131^1289^24
 ;;^UTILITY(U,$J,358.3,20504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20504,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,20504,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,20504,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,20505,0)
 ;;=V15.89^^131^1289^46
 ;;^UTILITY(U,$J,358.3,20505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20505,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,20505,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,20505,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,20506,0)
 ;;=V11.3^^131^1289^25
 ;;^UTILITY(U,$J,358.3,20506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20506,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,20506,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,20506,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,20507,0)
 ;;=V15.07^^131^1289^26
 ;;^UTILITY(U,$J,358.3,20507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20507,1,4,0)
 ;;=4^V15.07
